XML 44 R32.htm IDEA: XBRL DOCUMENT v3.24.1
Stockholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2023
Stockholders' Equity (Tables) [Line Items]  
Schedule of Grant Date Fair Market Value of Options Granted The Company determined the grant date fair market value of the options granted during the years ended December 31, 2023 and 2022 using the Black Scholes and Monte-Carlo Method as appropriate and the following assumptions:
   2023   2022 
Expected volatility   112–125%   123–127%
Expected term   1.04–5 Years    5 Years 
Risk free rate   3.52–4.92 %   2.14–3.75 %
Dividend rate   0.00%   0.00%
Schedule of Activity Related to Stock Options Activity related to stock options for the years ended December 31, 2023, and 2022 is summarized as follows:
       Weighted   Weighted     
       Average   Average   Aggregate 
   Number of   Exercise   Contractual   Intrinsic 
   Shares   Price   Life (Yrs.)   Value 
Outstanding, January 1, 2022   1,113,904   $51.84    6.7   $67,488,214 
Granted   248,169   $12.88    10.0   $
-
 
Exercised   (49,712)  $18.56    8.8    $ 
Forfeited/cancelled   (20,764)  $52.96    7.9   $
-
 
Outstanding, December 31, 2022   1,291,597   $6.48    6.7   $
-
 
Granted   877,250   $5.38    10.0   $3,576,759 
Exercised   (938)  $6.32    0.0   $
-
 
Forfeited/cancelled   (371,166)  $52.39    6.3   $
-
 
Outstanding, December 31, 2023   1,796,743   $25.20    6.5   $3,630,733 
Exercisable, December 31, 2023   1,073,349   $32.86    4.9   $1,502,214 
Schedule of Stock Option Information The following table summarizes stock option information as of December 31, 2023:
       Contractual     
Exercise Price  Outstanding   Life (Yrs.)   Exercisable 
$2.64 – $5.00   354,375    9.0    148,867 
$5.01 – $10.00   561,189    9.5    154,603 
$10.01 – $15.00   43,703    2.9    43,703 
$15.01 – $20.00   252,084    1.8    252,084 
$20.01 – $121.28   585,392    5.1    474,092 
    1,796,743    6.5    1,073,349 
Warrant [Member]  
Stockholders' Equity (Tables) [Line Items]  
Schedule of Company’s Warrant Activity The following is a summary of the Company’s warrant activity for the years ended December 31, 2023 and 2022:
       Weighted   Weighted 
       Average   Average 
   Number of   Exercise   Remaining 
   Shares   Price   Life 
Outstanding, January 1, 2022   175,482   $36.88     3.0 Years  
Granted   17,837   $29.60     5.0 Years  
Exercised/Cancelled   (39,636)  $33.20    
-
 
Outstanding, December 31, 2022   153,683   $36.96     2.0 Years  
Granted   454,461   $4.02     4.5 Years  
Exercised/Cancelled   (9,877)  $39.60    
-
 
Outstanding, December 31, 2023   598,267   $11.89    3.9 Years